Ari Maizel serves as Chief Commercial Officer at Axsome Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ari Maizel has executed 3 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved exercising options for 7,500 shares valued at $0.
Ari Maizel currently holds 31,210 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $0. This represents their equity stake as Chief Commercial Officer.
Based on SEC Form 4 filings, Ari Maizel has been a net seller of AXSM stock. They have purchased $0 and sold $1.4M worth of shares.
Ari Maizel's most recent insider trade was on Jan 21, 2026, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $184.44 |
| Discretionary |
| Jan 21, 2026 | AXSM | $530.5K | Option Exercise | 7,500 | $70.73 | Discretionary |